Educational resources

Guidelines in Practice has developed a range of educational resources—including animations, formulary decision guides, implementation checklists, supplements, and webinars—to support you with your learning and implementation of best practice. Items may contain pharmaceutical promotional information.

eLearning module_Deep dive on SGLT2 inhibitors_index image

Deep dive on SGLT2 inhibitors with a focus on Jardiance® (empagliflozin)

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This eLearning module has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice and Guidelines Learning. Products are discussed.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104397 April 2021

Deep dive on DPP-4 inhibitors

Deep dive on DPP-4 inhibitors with a focus on Trajenta® (linagliptin)

Promotional material from Boehringer Ingelheim Limited

This eLearning module and the associated videos have been commissioned and funded by Boehringer Ingelheim. The module and associated videos contain promotional content. For UK healthcare professionals.
View Trajenta® (linagliptin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104526 July 2021

Trajenta webinar index

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice.
View Trajenta® (linagliptin) prescribing and adverse events reporting information for:
Great Britain 
Northern Ireland
PC-GB-103485 | July 2021

asthma inhaler

The importance of inhaler choice

Commissioned by Boehringer Ingelheim Limited

Information intended for UK healthcare professionals only. This promotional webinar was commissioned and funded by Boehringer Ingelheim and developed in partnership with Guidelines in Practice
View prescribing information here.
PC-GB-104812
Date of preparation: June 2021

Advertisement

Alan-case-study-image

A cancer diagnosis can be overwhelming – Macmillan’s email support can help your patients.

This is promotional material from Macmillan Cancer Support.

Your patients can sign up for regular tailored emails from Macmillan to support them through diagnosis and beyond. With information ranging from treatment to the impact of cancer on money and work, tell your patients to sign up today. Learn more here

Doctor writing AS 216244365 Andrey Popov web optimised

In conversation: barriers to implementation of the NHS restructure and future opportunities

In the final In conversation video on the NHS restructure, Dr Karen Kirkham and Dr Anthony Cunliffe explore barriers to the success of the changes

Doctor + clipboard working on laptop

In conversation: potential benefits of the NHS restructure for practice and patients

In the second In conversation video on the NHS reorganisation, Dr Karen Kirkham and Dr Anthony Cunliffe talk about the emerging benefits of the changes

Doctor at computer660x440

In conversation: specifics and context of the NHS restructure

By Dr Karen Kirkham and Dr Anthony Cunliffe

In the first of a new series of In conversation videos, Dr Karen Kirkham and Dr Anthony Cunliffe discuss the details and backdrop of forthcoming changes to the NHS in England

Bronchiectasis video index image edit

Five things you need to know about… bronchiectasis

By Dr Kevin Gruffydd-Jones

In the first of a new series of videos, Dr Kevin Gruffydd-Jones highlights five things you need to know about bronchiectasis

5-minute video_Chronic respiratory conditions and COVID-19-v2

NICE guidance on respiratory conditions and COVID-19: 5-minute video

By Dr Kevin Gruffydd-Jones

Dr Kevin Gruffydd-Jones highlights important things you need to know about managing respiratory conditions in a COVID-19 context

Ipinnia XL (ropinirole hydrochloride) FDG

Ipinnia® XL (ropinirole hydrochloride) prolonged-release tablets

Commissioned by Ethypharm UK Ltd

This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-IPN-13  Date of preparation: September 2021

Steglatro FDG inxed image

Steglatro®▼ (Ertugliflozin)

Commissioned by MSD UK Ltd

This formulary decision guide was developed from content provided by MSD UK Ltd in a format developed by Guidelines in Practice.
View prescribing information and adverse event reporting
GB-STE-00433 | June 2021

Xaggitin XL (methylphenidate hydrochloride) FDG

Xaggitin XL (methylphenidate hydrochloride) prolonged-release tablets

Commissioned by Ethypharm UK Ltd

This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-XAG-20  Date of preparation: July 2021

FINAL index image

Trurapi▼ (insulin aspart 100 units/ml)

Commissioned by Sanofi Ltd

This formulary decision guide was developed from content provided by Sanofi Ltd in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
MAT-GB-2101070(v2.0) | Date of preparation: July 2021

Index image

EleCare®

Commissioned by Abbott

This formulary decision guide was developed from content provided by Abbott in a format developed by Guidelines in Practice.
UK—2100014 | Date of preparation: June 2021

Soprobec FDG image update_index image

Soprobec (beclometasone dipropionate) pMDI

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-SOP-0130 V2 March 2021

Prostap FDG

PROSTAP® DCS (leuprorelin acetate)

Commissioned by Takeda UK Ltd

This formulary decision guide was developed by Guidelines in Practice based on content and funding provided by Takeda UK Ltd. Information intended for healthcare professionals only.
View prescribing information here

C-APROM/UK/LEU/0075 February 2021

Nutramigen Puramino Index Image

Nutramigen* PURAMINO*

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines inPractice.
RB-M-18261 October 2020

Nutramigen LGG Index Image

Nutramigen* 1, 2 & 3 LGG®

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice.
RB-M-18259 October 2020

Front cover image

The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document

Commissioned by STADA incorporating Thornton & Ross

Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d  Date of preparation: August 2021

Index image

Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes

Supported by an educational grant from Sanofi Ltd

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd

heart ecg_AS

Improving outcomes in the management of patients with chronic coronary syndrome and stable anginal chest pain for the acute and general physician

Commissioned and funded by A. Menarini Farmaceutica Internazionale SRL

Information intended for UK healthcare professionals only.
This promotional supplement has been commissioned and funded by A. Menarini Farmaceutica Internazionale SRL and developed in partnership with Guidelines in Practice.
View Ranexa (ranolazine) prescribing information and adverse event reporting information here
PP-RA-UK-0627
Date of preparation: July 2021

FINAL index image

Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*

Commissioned by Accord UK Ltd

Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021

20210329 Prostap RTD_final COVER

Prostap® DCS (leuprorelin acetate)—a 3-monthly gonadotrophin-releasing hormone (GnRH) agonist treatment for breast cancer

Commissioned by Takeda UK Ltd

Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Takeda UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
C-APROM/UK/PRS/0152
Date of preparation: April 2021

Final version - GiP supplement (print version)

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103451 Date of preparation: January 2021

Front cover 20201202 Plenvu supplement December 2020 PI

Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK

Commissioned by Norgine Pharmaceuticals Limited

This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021

Emollient supplement_Index image

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines
Date of preparation: January 2021

Diabetes equipment vector

Showcasing local best practice in diabetes

This Guidelines in Practice supplement aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Optimised patient pathway for infertility

An optimised patient pathway for the treatment of heterosexual patients with infertility

Commissioned by Merck Serono Ltd

This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.

Malnutrition supplement

Identification and management of patients with malnutrition

Commissioned by Alliance Pharmaceuticals Ltd

This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

NICE acne checklist index image

Implementing the NICE guideline on the management of acne vulgaris

Supported by an educational grant from Galderma UK Ltd

Information intended for UK healthcare professionals only.

NICE Atrial fibrillation checklist

Checklist on the implementation of the NICE guideline on atrial fibrillation: diagnosis and management

Commissioned and funded by Daiichi Sankyo

This implementation checklist has been commissioned and funded by Daiichi Sankyo UK and developed in partnership with Guidelines in Practice.
View LIXIANA (edoxaban) prescribing and adverse event reporting information
EDX/21/0535 July 2021

FINAL Allergic rhinitis checklist image

Implementing the Guidelines algorithm on identifying and managing allergic rhinitis in the asthma population

Supported by an educational grant from Mylan

Information intended for healthcare professionals only.

Cosentyx (secukinumab) TA card

NICE Technology Appraisal 719: Secukinumab for treating non-radiographic axial spondyloarthritis

Commissioned by Novartis Pharmaceuticals UK Ltd

The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd. 
View Cosentyx (secukinumab) prescribing and adverse event reporting information
MLR ID 147195  August 2021

Evenity index image

Romosozumab▼ (Evenity®) 105mg solution for injection in prefilled pen SMC2280

Commissioned by UCB Pharma Ltd

The production of this Guidelines card has been commissioned by UCB Pharma Ltd. 
Amgen and UCB Pharma Ltd are co-developing Evenity®.
View prescribing information and adverse event reporting
UK-P-RM-OP-2000095 December 2020

PCDS AK guideline reprint - digital

Actinic keratosis (syn. solar keratosis)—Primary Care Dermatology Society

Commissioned by Almirall Ltd

The production, printing, and distribution of this Guidelines reprint has been commissioned and funded by Almirall Ltd. Information intended for UK healthcare professionals only.

UK-ATK-2100001 March 2021

Osteoarthritis-related pain

Resources provided by Pfizer Ltd.
PP-PPF-GBR-0130 Date of preparation: June 2021

K. Kavia and V. Mashru–Sponsored symposium: Caring for the ageing patient: right drug, right patient, right time

Ketan Kavia and Vishal Mashru–Sponsored symposium: Caring for the ageing patient: right drug, right patient, right time

Commissioned by Daiichi Sankyo

This video has been commissioned and funded by Daiichi Sankyo and developed in partnership with Guidelines Live. Please see the bottom of the page for the full disclaimer.
EDX/21/0403   Date of preparation: May 2021